|
US7157555B1
(en)
*
|
1997-08-08 |
2007-01-02 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7829084B2
(en)
*
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
EA009056B1
(ru)
|
2002-12-20 |
2007-10-26 |
Амген, Инк. |
Связывающие агенты, ингибирующие миостатин
|
|
AU2004239244C1
(en)
|
2003-05-06 |
2015-04-23 |
Bioverativ Therapeutics Inc. |
Clotting factor-Fc chimeric proteins to treat hemophilia
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
US7850970B2
(en)
|
2003-08-26 |
2010-12-14 |
The Regents Of The University Of Colorado |
Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
|
|
EP1682584B1
(en)
*
|
2003-11-13 |
2013-04-17 |
Hanmi Science Co., Ltd. |
A pharmaceutical composition comprising an immunoglobulin fc region as a carrier
|
|
KR101135244B1
(ko)
*
|
2007-11-29 |
2012-04-24 |
한미사이언스 주식회사 |
인슐린 분비 펩타이드 결합체를 포함하는 비만 관련질환 치료용 조성물
|
|
US8110665B2
(en)
|
2003-11-13 |
2012-02-07 |
Hanmi Holdings Co., Ltd. |
Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
|
|
US8263084B2
(en)
*
|
2003-11-13 |
2012-09-11 |
Hanmi Science Co., Ltd |
Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
|
|
SI2348114T1
(sl)
*
|
2004-04-21 |
2018-11-30 |
Alexion Pharmaceuticals, Inc. |
Konjugati za dodajanje kostem in njihova uporaba za ciljanje beljakovin na kosti
|
|
US20070081984A1
(en)
|
2005-10-11 |
2007-04-12 |
Shunji Tomatsu |
Compositions and methods for treating hypophosphatasia
|
|
WO2006010057A2
(en)
*
|
2004-07-08 |
2006-01-26 |
Amgen Inc. |
Therapeutic peptides
|
|
CA2580796C
(en)
|
2004-09-24 |
2013-03-26 |
Amgen Inc. |
Modified fc molecules having peptides inserted in internal loop regions
|
|
KR100594607B1
(ko)
*
|
2004-11-03 |
2006-06-30 |
재단법인서울대학교산학협력재단 |
신규한 경구투여용 재조합 인간 성장호르몬 분비미생물제제 및 그 제조방법
|
|
EP1833510A4
(en)
*
|
2004-12-27 |
2010-02-10 |
Progenics Pharmaceuticals Neva |
ORAL ADMINISTRATION ANTITOXIN ANTIBODIES AND METHODS OF MAKING AND USING THE SAME
|
|
JP2008536477A
(ja)
*
|
2005-02-14 |
2008-09-11 |
アポロ ライフ サイエンシズ リミテッド |
分子およびそのキメラ分子
|
|
KR100754667B1
(ko)
*
|
2005-04-08 |
2007-09-03 |
한미약품 주식회사 |
비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물
|
|
US7833979B2
(en)
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
HUE026303T2
(hu)
|
2005-07-25 |
2016-06-28 |
Emergent Product Dev Seattle |
B-sejt csökkentés CD37-specifikus és CD20-specifikus kapcsoló molekulák alkalmazásával
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
CN101258164B
(zh)
*
|
2005-08-16 |
2013-05-01 |
韩美科学株式会社 |
用于大量生产缺失起始甲硫氨酸残基的免疫球蛋白Fc区的方法
|
|
KR100824505B1
(ko)
*
|
2005-08-16 |
2008-04-22 |
한미약품 주식회사 |
개시 메티오닌 잔기가 제거된 면역글로불린 Ｆｃ 영역의대량 생산방법
|
|
CN101534865A
(zh)
*
|
2005-10-19 |
2009-09-16 |
Ibc药品公司 |
生物活性装配体的制备方法及其用途
|
|
CA2630415A1
(en)
*
|
2005-10-20 |
2007-04-26 |
The Scripps Research Institute |
Fc labeling for immunostaining and immunotargeting
|
|
AR056142A1
(es)
*
|
2005-10-21 |
2007-09-19 |
Amgen Inc |
Metodos para generar el anticuerpo igg monovalente
|
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
|
EP1973576B1
(en)
|
2005-11-28 |
2019-05-15 |
Genmab A/S |
Recombinant monovalent antibodies and methods for production thereof
|
|
MX2008007324A
(es)
*
|
2005-12-06 |
2009-03-04 |
Amgen Inc |
Usos de antagonistas de miostatina.
|
|
CN100475270C
(zh)
|
2006-01-20 |
2009-04-08 |
清华大学 |
一种治疗肿瘤的药物及其应用
|
|
CN101002945B
(zh)
|
2006-01-20 |
2012-09-05 |
清华大学 |
一种用于肿瘤治疗的新型复合物
|
|
MX2008015524A
(es)
*
|
2006-06-12 |
2009-01-13 |
Trubion Pharmaceuticals Inc |
Proteinas de union multivalentes monocatenarias con funcion efectora.
|
|
EA017152B1
(ru)
*
|
2006-08-28 |
2012-10-30 |
Арес Трейдинг С.А. |
СПОСОБ ОЧИСТКИ Fc-СОДЕРЖАЩИХ БЕЛКОВ
|
|
US20140147441A1
(en)
*
|
2006-09-12 |
2014-05-29 |
The General Hospital Corporation |
Compositions containing alpha-1-antitrypsin and methods for use
|
|
EP2081602A2
(en)
|
2006-10-25 |
2009-07-29 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
US20080181903A1
(en)
*
|
2006-12-21 |
2008-07-31 |
Pdl Biopharma, Inc. |
Conjugate of natriuretic peptide and antibody constant region
|
|
JP2008169195A
(ja)
*
|
2007-01-05 |
2008-07-24 |
Hanmi Pharmaceutical Co Ltd |
キャリア物質を用いたインスリン分泌ペプチド薬物結合体
|
|
CN101219219B
(zh)
|
2007-01-10 |
2013-02-13 |
北京普罗吉生物科技发展有限公司 |
包含血管抑素或其片段的复合物、其制备方法及应用
|
|
WO2008127780A2
(en)
*
|
2007-02-21 |
2008-10-23 |
Nantero, Inc. |
Symmetric touch screen system with carbon nanotube-based transparent conductive electrode pairs
|
|
US8501678B2
(en)
|
2007-03-06 |
2013-08-06 |
Atara Biotherapeutics, Inc. |
Variant activin receptor polypeptides and uses thereof
|
|
US7947646B2
(en)
|
2007-03-06 |
2011-05-24 |
Amgen Inc. |
Variant activin receptor polypeptides
|
|
WO2013106175A1
(en)
|
2011-12-19 |
2013-07-18 |
Amgen Inc. |
Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
|
|
US8420779B2
(en)
|
2007-05-22 |
2013-04-16 |
Amgen Inc. |
Compositions and methods for producing bioactive fusion proteins
|
|
CA2687377C
(en)
*
|
2007-05-30 |
2013-05-14 |
Genexine Co., Ltd. |
Immunoglobulin fusion proteins
|
|
EP2167669A2
(en)
|
2007-05-31 |
2010-03-31 |
Genmab A/S |
Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals
|
|
MX394440B
(es)
|
2007-06-01 |
2025-03-24 |
Univ Maryland |
Agentes de union al receptor de la region constante fc de inmunoglobulina.
|
|
US20100310561A1
(en)
*
|
2007-06-06 |
2010-12-09 |
Boehringer Ingelheim International Gmbh |
Natriuretic fusion proteins
|
|
CN101842389A
(zh)
*
|
2007-06-12 |
2010-09-22 |
惠氏有限责任公司 |
抗cd20治疗组合物和方法
|
|
WO2009023386A2
(en)
*
|
2007-07-06 |
2009-02-19 |
Trubion Pharmaceuticals, Inc. |
Binding peptides having a c-terminally disposed specific binding domain
|
|
US8492347B2
(en)
*
|
2007-10-17 |
2013-07-23 |
The Regents Of The University Of California |
Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus
|
|
US20090181037A1
(en)
*
|
2007-11-02 |
2009-07-16 |
George Heavner |
Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses
|
|
AU2009234277B2
(en)
*
|
2008-04-11 |
2014-12-04 |
Aptevo Research And Development Llc |
CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
|
|
US9636420B2
(en)
|
2008-07-23 |
2017-05-02 |
Hanmi Science Co., Ltd. |
Polypeptide complex comprising non-peptidyl polymer having three functional ends
|
|
RU2457856C2
(ru)
*
|
2008-08-05 |
2012-08-10 |
Виктор Владимирович Чалов |
Композиция, обладающая противовирусным и антимикробным действием, для перорального применения
|
|
CN104231070B
(zh)
*
|
2008-08-07 |
2017-09-01 |
益普生制药股份有限公司 |
N‑端修饰的葡萄糖依赖性促胰岛素多肽（gip）类似物
|
|
WO2010016940A2
(en)
*
|
2008-08-07 |
2010-02-11 |
Ipsen Pharma S.A.S. |
Analogues of glucose-dependent insulinotropic polypeptide
|
|
EA020005B1
(ru)
|
2008-08-07 |
2014-07-30 |
Ипсен Фарма С.А.С. |
Аналоги глюкозазависимого инсулинотропного полипептида
|
|
EP2350118B1
(en)
*
|
2008-09-19 |
2016-03-30 |
Nektar Therapeutics |
Carbohydrate-based drug delivery polymers and conjugates thereof
|
|
US20110206633A1
(en)
*
|
2008-09-19 |
2011-08-25 |
Nektar Therapectics |
Polymer conjugates of cd-np peptides
|
|
WO2010051335A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Amgen Inc. |
Materials and methods relating to stem cell mobilization by multi-pegylated granulocyte colony stimulating factor
|
|
MY159483A
(en)
|
2008-11-26 |
2017-01-13 |
Amgen Inc |
Variants of activin iib receptor polypeptides and uses thereof
|
|
US20100143353A1
(en)
*
|
2008-12-04 |
2010-06-10 |
Mosser David M |
POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (lgG) AND METHODS OF USING THE SAME
|
|
US20100158893A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Baxter International Inc. |
Systems and methods for obtaining immunoglobulin from blood
|
|
AR075029A1
(es)
*
|
2009-01-19 |
2011-03-02 |
Hanmi Pharm Ind Co Ltd |
Metodo para producir una proteina o un peptido fisiologicamente activo usando un fragmento de inmunoglobulina
|
|
US9238878B2
(en)
|
2009-02-17 |
2016-01-19 |
Redwood Bioscience, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
|
JP2012518419A
(ja)
|
2009-02-25 |
2012-08-16 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖操作酵母ピチア・パストリスにおけるガラクトース同化経路の代謝操作
|
|
CA2756197A1
(en)
*
|
2009-03-24 |
2010-09-30 |
Bayer Healthcare Llc |
Factor viii variants and methods of use
|
|
RU2503688C2
(ru)
*
|
2009-04-22 |
2014-01-10 |
Алтеоген, Инк |
Слитый белок или пептид с увеличенным временем полужизни in vivo, поддерживаемый за счет замедленного высвобождения in vivo, и способ увеличения времени полужизни in vivo с его применением
|
|
CA2779577A1
(en)
*
|
2009-11-02 |
2011-05-05 |
Therapeomic Ag |
Stabilized protein formulations and use thereof
|
|
US9629920B2
(en)
|
2009-12-18 |
2017-04-25 |
Exodos Life Sciences Limited Partnership |
Methods and compositions for stable liquid drug formulations
|
|
WO2011075185A1
(en)
|
2009-12-18 |
2011-06-23 |
Oligasis |
Targeted drug phosphorylcholine polymer conjugates
|
|
AU2011207915B2
(en)
*
|
2010-01-19 |
2013-07-11 |
Hanmi Science Co., Ltd. |
Liquid formulations for long-acting G-CSF conjugate
|
|
JP5638628B2
(ja)
*
|
2010-01-19 |
2014-12-10 |
ハンミ サイエンス カンパニー リミテッドＨａｎｍｉ Ｓｃｉｅｎｃｅｃｏ．，Ｌｔｄ． |
持続型エリスロポエチン結合体の液剤
|
|
WO2011093470A1
(ja)
*
|
2010-01-28 |
2011-08-04 |
協和発酵キリン株式会社 |
Bone morphogenetic protein receptor 1B(BMPR1B)細胞外ドメイン又はその変異体を含む蛋白質を含有する骨疾患治療用医薬組成物
|
|
MX2012009802A
(es)
|
2010-02-24 |
2012-09-12 |
Merck Sharp & Dohme |
Metodo para incrementar la ocupacion del sitio de n-glucosilacion en glucoproteinas terapeuticas producidas en pichia pastoris.
|
|
DK2977088T3
(en)
*
|
2010-03-08 |
2017-10-09 |
Ge Healthcare Bioprocess R&D Ab |
IMMUNOGLOBULIN G FC REGION BINDING POLYPEPTIDE
|
|
AR080993A1
(es)
|
2010-04-02 |
2012-05-30 |
Hanmi Holdings Co Ltd |
Formulacion de accion prolongada de interferon beta donde se usa un fragmento de inmunoglobulina
|
|
AR081066A1
(es)
|
2010-04-02 |
2012-06-06 |
Hanmi Holdings Co Ltd |
Conjugado de insulina donde se usa un fragmento de inmunoglobulina
|
|
US9981017B2
(en)
|
2010-04-02 |
2018-05-29 |
Hanmi Science Co., Ltd. |
Insulin conjugate using an immunoglobulin fragment
|
|
AR081755A1
(es)
*
|
2010-04-02 |
2012-10-17 |
Hanmi Holdings Co Ltd |
Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
|
|
CA2797865A1
(en)
|
2010-04-30 |
2011-11-03 |
Alexion Pharma International Sarl |
Methods, compositions, and kits for the treatment of matrix mineralization disorders
|
|
WO2011146902A1
(en)
*
|
2010-05-21 |
2011-11-24 |
Merrimack Pharmaceuticals, Inc. |
Bi-specific fusion proteins
|
|
KR101330868B1
(ko)
*
|
2010-06-08 |
2013-11-18 |
한미사이언스 주식회사 |
면역글로불린 단편을 이용한 인슐린 유도체 약물 결합체
|
|
KR20120002129A
(ko)
*
|
2010-06-30 |
2012-01-05 |
한미홀딩스 주식회사 |
면역글로불린 단편을 이용한 제７인자（Ｆａｃｔｏｒ Ⅶａ）약물 결합체
|
|
KR101337797B1
(ko)
*
|
2010-07-14 |
2013-12-06 |
한미사이언스 주식회사 |
지속형 인간 성장 호르몬 결합체 액상 제제
|
|
KR101382593B1
(ko)
*
|
2010-07-21 |
2014-04-10 |
한미사이언스 주식회사 |
신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물
|
|
TR201906652T4
(tr)
|
2010-07-28 |
2019-05-21 |
Gliknik Inc |
Kademeli multimerize immünoglobülin fc bileşimleri oluşturmak için doğal insan protein fragmanları içeren füzyon proteinleri.
|
|
WO2012053828A2
(ko)
*
|
2010-10-20 |
2012-04-26 |
주식회사 한독약품 |
인간 인터루킨-1 수용체 길항제-하이브리드 Ｆｃ 융합단백질
|
|
US8883134B2
(en)
|
2010-10-20 |
2014-11-11 |
Handok Pharmaceuticals, Inc. |
Human interleukin-1 receptor antagonist—hybrid Fc fusion protein
|
|
KR101303388B1
(ko)
*
|
2010-10-26 |
2013-09-03 |
한미사이언스 주식회사 |
지속형 인터페론 알파 결합체의 액상 제제
|
|
EP2465536A1
(en)
|
2010-12-14 |
2012-06-20 |
CSL Behring AG |
CD89 activation in therapy
|
|
EP2655413B1
(en)
|
2010-12-23 |
2019-01-16 |
F.Hoffmann-La Roche Ag |
Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
|
|
WO2012088608A1
(en)
|
2010-12-27 |
2012-07-05 |
Enobia Canada Limited Partnership |
Compositions comprising natriuretic peptides and methods of use thereof
|
|
AU2012205301B2
(en)
|
2011-01-14 |
2017-01-05 |
Redwood Bioscience, Inc. |
Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
|
|
CN102309765B
(zh)
*
|
2011-02-28 |
2013-10-16 |
北京韩美药品有限公司 |
包含免疫球蛋白Fc片段作为载体的长效抗凝多肽及其制备方法
|
|
CN103533951B
(zh)
|
2011-04-08 |
2017-04-19 |
安姆根有限公司 |
使用生长分化因子15(gdf‑15)治疗或改善代谢障碍的方法
|
|
UA113626C2
(xx)
*
|
2011-06-02 |
2017-02-27 |
|
Композиція для лікування діабету, що містить кон'югат інсуліну тривалої дії та кон'югат інсулінотропного пептиду тривалої дії
|
|
CN102807619B
(zh)
*
|
2011-06-03 |
2016-08-03 |
北京韩美药品有限公司 |
含有免疫球蛋白Fc片段和粒细胞-巨噬细胞集落刺激因子的复合物及其药物组合物
|
|
PE20140765A1
(es)
|
2011-06-10 |
2014-06-14 |
Hanmi Science Co Ltd |
Derivados de oxintomodulina novedosos y composicion farmaceutica para tratar la obesidad que comprende los mismos
|
|
UA125895C2
(uk)
*
|
2011-06-17 |
2022-07-06 |
Ханмі Сайенс Ко., Лтд. |
КОН'ЮГАТ, ЩО МІСТИТЬ ПОХІДНУ ОКСИНТОМОДУЛІНУ ТА Fc-ДІЛЯНКУ ІМУНОГЛОБУЛІНУ, ТА ЙОГО ЗАСТОСУВАННЯ
|
|
KR102103476B1
(ko)
*
|
2011-06-24 |
2020-04-23 |
더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 |
알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도
|
|
EP3569243A1
(en)
*
|
2011-06-28 |
2019-11-20 |
Inhibrx, LP |
Serpin fusion polypeptides and methods of use thereof
|
|
US10400029B2
(en)
|
2011-06-28 |
2019-09-03 |
Inhibrx, Lp |
Serpin fusion polypeptides and methods of use thereof
|
|
KR20140068861A
(ko)
*
|
2011-06-28 |
2014-06-09 |
인히브릭스 엘엘씨 |
Wap 도메인 융합 폴리펩티드 및 이의 이용 방법
|
|
EP2753348B1
(en)
*
|
2011-09-05 |
2019-12-11 |
Hanmi Science Co., Ltd. |
Pharmaceutical compositions comprising an interferon alpha conjugate and gemcitabine for the treatment of cancer
|
|
US9458214B2
(en)
*
|
2011-09-26 |
2016-10-04 |
Novartis Ag |
Dual function fibroblast growth factor 21 proteins
|
|
WO2013051900A2
(en)
*
|
2011-10-06 |
2013-04-11 |
Hanmi Science Co., Ltd. |
Blood coagulation factor ⅶ and ⅶa derivatives, conjugates and complexes comprising the same, and use thereof
|
|
EP2784080B1
(en)
*
|
2011-10-31 |
2019-12-18 |
Shimadzu Corporation |
Peptide-hinge-free flexible antibody-like molecule
|
|
KR20130049671A
(ko)
|
2011-11-04 |
2013-05-14 |
한미사이언스 주식회사 |
생리활성 폴리펩타이드 결합체 제조 방법
|
|
CN103172745A
(zh)
*
|
2011-12-21 |
2013-06-26 |
北京韩美药品有限公司 |
包含免疫球蛋白Fc片段的长效人内皮抑素
|
|
KR101895047B1
(ko)
|
2011-12-30 |
2018-09-06 |
한미사이언스 주식회사 |
면역글로불린 단편을 이용한 위치 특이적 글루카곤 유사 펩타이드-2 약물 결합체
|
|
KR102041412B1
(ko)
*
|
2011-12-30 |
2019-11-11 |
한미사이언스 주식회사 |
면역글로불린 Ｆｃ 단편 유도체
|
|
CN104520321A
(zh)
|
2012-01-09 |
2015-04-15 |
斯克利普斯研究所 |
超长互补决定区及其用途
|
|
US20150011431A1
(en)
|
2012-01-09 |
2015-01-08 |
The Scripps Research Institute |
Humanized antibodies
|
|
WO2013106589A1
(en)
|
2012-01-10 |
2013-07-18 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
EP3683228A3
(en)
|
2012-01-26 |
2020-07-29 |
Amgen Inc. |
Growth differentiation factor 15 (gdf-15) polypeptides
|
|
AR090281A1
(es)
*
|
2012-03-08 |
2014-10-29 |
Hanmi Science Co Ltd |
Proceso mejorado para la preparacion de un complejo polipeptidico fisiologicamente activo
|
|
EP2636681A1
(en)
|
2012-03-09 |
2013-09-11 |
CSL Behring AG |
Process for enriching IgA
|
|
EP2636684A1
(en)
|
2012-03-09 |
2013-09-11 |
CSL Behring AG |
Prevention of infection
|
|
KR102142261B1
(ko)
|
2012-03-09 |
2020-08-11 |
체에스엘 베링 아게 |
분비형 면역글로불린을 포함하는 조성물
|
|
US10064951B2
(en)
*
|
2012-03-30 |
2018-09-04 |
Hanmi Science Co., Ltd. |
Liquid formulation of highly concentrated long-acting human growth hormone conjugate
|
|
US9809641B2
(en)
*
|
2012-04-23 |
2017-11-07 |
Nrl Pharma, Inc. |
Lactoferrin fusion protein and method for preparation thereof
|
|
US10052366B2
(en)
|
2012-05-21 |
2018-08-21 |
Alexion Pharmaceuticsl, Inc. |
Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
|
|
HUE043552T2
(hu)
|
2012-06-08 |
2019-09-30 |
Sutro Biopharma Inc |
Antitestek, amelyek tartalmaznak helyspecifikus nem természetes aminosav maradékokat, eljárások elõállításukra és eljárások használatukra
|
|
ES2611788T3
(es)
|
2012-06-26 |
2017-05-10 |
Sutro Biopharma, Inc. |
Proteínas de Fc modificadas que comprenden residuos de aminoácidos no naturales específicos del sitio, conjugados de las mismas, métodos para su preparación y métodos para su uso
|
|
RU2015100656A
(ru)
*
|
2012-06-27 |
2016-08-20 |
Ф. Хоффманн-Ля Рош Аг |
Способ получения конъюгатов fc-фрагмента антитела, включающих по меньшей мере одну связывающую группировку, которая специфически связывается с мишенью, и их применения
|
|
RU2639287C2
(ru)
|
2012-06-27 |
2017-12-20 |
Ф. Хоффманн-Ля Рош Аг |
Способ отбора и получения высокоселективных и мультиспецифичных нацеливающих групп с заданными свойствами, включающих по меньшей мере две различные связывающие группировки, и их применения
|
|
US10441665B2
(en)
|
2012-07-25 |
2019-10-15 |
Hanmi Pharm. Co., Ltd. |
Liquid formulation of long acting insulinotropic peptide conjugate
|
|
AR094821A1
(es)
*
|
2012-07-25 |
2015-09-02 |
Hanmi Pharm Ind Co Ltd |
Formulación líquida de un conjugado de péptido insulinotrópico de acción prolongada
|
|
AR091902A1
(es)
|
2012-07-25 |
2015-03-11 |
Hanmi Pharm Ind Co Ltd |
Formulacion liquida de un conjugado de insulina de accion prolongada
|
|
AR092862A1
(es)
|
2012-07-25 |
2015-05-06 |
Hanmi Pharm Ind Co Ltd |
Formulacion liquida de insulina de accion prolongada y un peptido insulinotropico y metodo de preparacion
|
|
KR101968344B1
(ko)
|
2012-07-25 |
2019-04-12 |
한미약품 주식회사 |
옥신토모듈린 유도체를 포함하는 고지혈증 치료용 조성물
|
|
CN104718223A
(zh)
|
2012-08-20 |
2015-06-17 |
格利克尼克股份有限公司 |
具有抗原结合和多价FCγ受体结合活性的分子
|
|
EP2890402B1
(en)
|
2012-08-31 |
2019-04-17 |
Sutro Biopharma, Inc. |
Modified amino acids comprising an azido group
|
|
KR20150052085A
(ko)
|
2012-09-14 |
2015-05-13 |
에프. 호프만-라 로슈 아게 |
2개 이상의 상이한 단위를 포함하는 분자의 제조 및 선별 방법, 및 이의 용도
|
|
WO2014043523A1
(en)
|
2012-09-14 |
2014-03-20 |
The Johns Hopkins University |
Compositions and methods for rendering tumor cells susceptible to cd8+ t cell-mediated killing
|
|
KR101993393B1
(ko)
*
|
2012-11-06 |
2019-10-01 |
한미약품 주식회사 |
옥신토모듈린 유도체를 포함하는 당뇨병 또는 비만성 당뇨병 치료용 조성물
|
|
WO2014073842A1
(en)
|
2012-11-06 |
2014-05-15 |
Hanmi Pharm. Co., Ltd. |
Liquid formulation of protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment
|
|
WO2014110368A1
(en)
*
|
2013-01-11 |
2014-07-17 |
The California Institute For Biomedical Research |
Bovine fusion antibodies
|
|
CN103217489B
(zh)
*
|
2013-01-15 |
2016-03-09 |
珠海市丽珠单抗生物技术有限公司 |
一种测定蛋白纯化工艺过程中样品的糖基化和末端修饰情况的方法
|
|
KR102073748B1
(ko)
|
2013-01-31 |
2020-02-05 |
한미약품 주식회사 |
재조합 효모 형질전환체 및 이를 이용하여 면역글로불린 단편을 생산하는 방법
|
|
SG11201505960VA
(en)
|
2013-02-01 |
2015-08-28 |
Santa Maria Biotherapeutics Inc |
Administration of an anti-activin-a compound to a subject
|
|
AU2014219037A1
(en)
|
2013-02-22 |
2015-08-13 |
Zoetis Services Llc |
In ovo administration of growth factors for improving poultry performance
|
|
SG11201506937RA
(en)
*
|
2013-03-05 |
2015-10-29 |
Hanmi Pharm Ind Co Ltd |
Improved preparation method for high-yield production of physiologically active polypeptide conjugate
|
|
JP2016511275A
(ja)
|
2013-03-11 |
2016-04-14 |
ノヴォ・ノルディスク・ヘルス・ケア・アーゲー |
成長ホルモン化合物
|
|
US20140271641A1
(en)
*
|
2013-03-14 |
2014-09-18 |
University Of Guelph |
Thrombospondin-1 polypeptides and methods of using same
|
|
EA037906B1
(ru)
|
2013-03-15 |
2021-06-04 |
Биовератив Терапьютикс Инк. |
Препараты полипептида фактора ix
|
|
DK2970921T3
(en)
|
2013-03-15 |
2019-01-14 |
Atyr Pharma Inc |
Histidyl-tRNA synthetase-Fc conjugates
|
|
KR101895634B1
(ko)
*
|
2013-05-31 |
2018-09-05 |
한미약품 주식회사 |
변이된 힌지 영역을 포함하는 IgG4 Fc 단편
|
|
ES2658039T3
(es)
|
2013-07-10 |
2018-03-08 |
Sutro Biopharma, Inc. |
Anticuerpos que comprenden múltiples residuos de aminoácidos no naturales sitio-específicos, métodos para su preparación y métodos de uso
|
|
AR096891A1
(es)
*
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo
|
|
AR096890A1
(es)
*
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugando fc de inmunoglobulina, que mantiene la afinidad de unión del fragmento fc de la inmunoglobulina a fcrn
|
|
CN111518199A
(zh)
|
2013-07-18 |
2020-08-11 |
图鲁斯生物科学有限责任公司 |
具有超长互补决定区的人源化抗体
|
|
EA037355B1
(ru)
|
2013-07-31 |
2021-03-17 |
Эмджен Инк. |
Конструкции на основе фактора дифференцировки и роста 15 (gdf-15)
|
|
AU2014312190A1
(en)
|
2013-08-28 |
2016-02-18 |
Bioasis Technologies Inc. |
CNS-targeted conjugates of antibodies
|
|
LT3041513T
(lt)
|
2013-09-08 |
2020-11-25 |
Kodiak Sciences Inc. |
Viii faktoriaus cviterioninių polimerų konjugatai
|
|
JP6886816B2
(ja)
|
2013-09-09 |
2021-06-16 |
カニムガイド セラピューティックス アーベー |
免疫系調節薬
|
|
CN105848645A
(zh)
|
2013-09-27 |
2016-08-10 |
韩美药品株式会社 |
持续型人生长激素制剂
|
|
US10006165B2
(en)
*
|
2013-09-30 |
2018-06-26 |
3M Innovative Properties Company |
Fibers and wipes with epoxidized fatty ester disposed thereon, and methods
|
|
PL3068797T3
(pl)
|
2013-11-11 |
2020-06-29 |
Wake Forest University Health Sciences |
Konstrukty wielowalentnego celowania w nowotwory
|
|
MA46146A1
(fr)
|
2014-01-20 |
2020-12-31 |
Hanmi Pharm Ind Co Ltd |
Insuline a action prolongée et utilisation associée
|
|
WO2015112597A1
(en)
*
|
2014-01-21 |
2015-07-30 |
Belmont Biosciences, Inc. |
Variants of igg fc with limited amine groups that retain functional properties
|
|
CN106488933A
(zh)
*
|
2014-03-31 |
2017-03-08 |
韩美药品株式会社 |
通过使用免疫球蛋白Fc片段连接改善蛋白质和肽的溶解度的方法
|
|
US10744204B2
(en)
*
|
2014-04-11 |
2020-08-18 |
Medimmune, Llc |
Conjugated compounds comprising cysteine-engineered antibodies
|
|
EP3137495A4
(en)
*
|
2014-04-28 |
2017-11-15 |
The National Institute for Biotechnology in the Negev, Ltd. |
Variants of dr3 and use thereof
|
|
KR20150133576A
(ko)
*
|
2014-05-20 |
2015-11-30 |
삼성전자주식회사 |
화학적 개질된 표적화 단백질 및 그의 이용
|
|
AR100639A1
(es)
|
2014-05-29 |
2016-10-19 |
Hanmi Pharm Ind Co Ltd |
Composición para tratar diabetes que comprende conjugados de análogos de insulina de acción prolongada y conjugados de péptidos insulinotrópicos de acción prolongada
|
|
TWI684458B
(zh)
|
2014-05-30 |
2020-02-11 |
南韓商韓美藥品股份有限公司 |
包含胰島素及ｇｌｐ-１/昇糖素雙重促效劑之治療糖尿病之組成物
|
|
CA2952532A1
(en)
*
|
2014-06-27 |
2015-12-30 |
Innate Pharma |
Multispecific antigen binding proteins
|
|
JP6822849B2
(ja)
|
2014-06-27 |
2021-01-27 |
イナート・ファルマ・ソシエテ・アノニムＩｎｎａｔｅ Ｐｈａｒｍａ Ｐｈａｒｍａ Ｓ．Ａ． |
多重特異的ＮＫｐ４６結合タンパク質
|
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
|
WO2016007873A1
(en)
|
2014-07-11 |
2016-01-14 |
The Regents Of The University Of Michigan |
Compositions and methods for treating craniosynostosis
|
|
AU2015294389B2
(en)
|
2014-07-24 |
2021-04-29 |
Genentech, Inc. |
Methods of conjugating an agent to a thiol moiety in a protein that contains at least one trisulfide bond
|
|
TWI802396B
(zh)
|
2014-09-16 |
2023-05-11 |
南韓商韓美藥品股份有限公司 |
長效glp-1/高血糖素受體雙促效劑治療非酒精性脂肝疾病之用途
|
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
|
JP6849590B2
(ja)
*
|
2014-10-17 |
2021-03-24 |
コディアック サイエンシーズ インコーポレイテッドＫｏｄｉａｋ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． |
ブチリルコリンエステラーゼ両性イオン性ポリマーコンジュゲート
|
|
CA2967851C
(en)
|
2014-12-05 |
2024-02-27 |
Alexion Pharmaceuticals, Inc. |
Treating seizure with recombinant alkaline phosphatase
|
|
KR102418477B1
(ko)
|
2014-12-30 |
2022-07-08 |
한미약품 주식회사 |
글루카곤 유도체
|
|
PE20171154A1
(es)
|
2014-12-30 |
2017-08-16 |
Hanmi Pharm Ind Co Ltd |
Derivados de glucagon con estabilidad mejorada
|
|
JP6868561B2
(ja)
|
2015-01-28 |
2021-05-12 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
アルカリホスファターゼ欠損を有する被験者を治療する方法
|
|
WO2016144650A1
(en)
|
2015-03-06 |
2016-09-15 |
Canimguide Therapeutics Ab |
Immune system modulators and compositions
|
|
JP6810702B2
(ja)
*
|
2015-04-06 |
2021-01-06 |
アクセルロン ファーマ インコーポレイテッド |
シングルアームｉ型およびｉｉ型受容体融合タンパク質およびその使用
|
|
SMT202100294T1
(it)
|
2015-04-22 |
2021-07-12 |
Biogen Ma Inc |
Proteine trappola del liganto acriib ibride innovative per il trattamento di patologie da deperimento muscolare
|
|
EP3288965B1
(en)
*
|
2015-04-29 |
2019-06-26 |
Mediolanum Farmaceutici S.p.A. |
A soluble chimeric interleukin-10 receptor and therapeutic use thereof
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
JP6983075B2
(ja)
|
2015-06-02 |
2021-12-17 |
ノヴォ ノルディスク アー／エス |
極性の組換え延長部を有するインスリン
|
|
US11820807B2
(en)
*
|
2015-06-12 |
2023-11-21 |
Ubi Pharma Inc |
Immunoglobulin fusion proteins and uses thereof
|
|
ES2983120T3
(es)
*
|
2015-06-12 |
2024-10-21 |
Ubi Pharma Inc |
Proteínas de fusión de inmunoglobulinas y usos de las mismas
|
|
EP3313881A1
(en)
|
2015-06-23 |
2018-05-02 |
Innate Pharma |
Multispecific nk engager proteins
|
|
KR102005456B1
(ko)
*
|
2015-06-30 |
2019-07-30 |
한미약품 주식회사 |
신규 글루카곤 유도체 및 이의 지속형 결합체를 포함하는 조성물
|
|
DK3325011T6
(da)
|
2015-07-24 |
2023-05-15 |
Gliknik Inc |
Fusionsproteiner af humane proteinfragmenter til fremstilling af ordnede multimeriserede immunoglobulin Fc-sammensætninger med forstærket komplementbinding
|
|
US11123436B2
(en)
|
2015-07-24 |
2021-09-21 |
Hanmi Pharm. Co., Ltd. |
Method of preparing physiologically active polypeptide conjugate
|
|
CA2993358A1
(en)
|
2015-08-17 |
2017-02-23 |
Alexion Pharmaceuticals, Inc. |
Manufacturing of alkaline phosphatases
|
|
UY36870A
(es)
|
2015-08-28 |
2017-03-31 |
Hanmi Pharm Ind Co Ltd |
Análogos de insulina novedosos
|
|
BR112018005573A2
(pt)
|
2015-09-21 |
2019-01-22 |
Aptevo Research And Development Llc |
?polipeptídeos de ligação a cd3?
|
|
US11389508B2
(en)
*
|
2015-09-24 |
2022-07-19 |
Hanmi Pharm. Co., Ltd. |
Protein complex by use of a specific site of an immunoglobulin fragment for linkage
|
|
TW201718629A
(zh)
*
|
2015-09-25 |
2017-06-01 |
韓美藥品股份有限公司 |
包含多個生理多肽及免疫球蛋白Ｆｃ區之蛋白質接合物
|
|
WO2017058822A1
(en)
|
2015-09-28 |
2017-04-06 |
Alexion Pharmaceuticals, Inc. |
Identifying effective dosage regimens for tissue non-specific alkaline phosphatase (tnsalp)-enzyme replacement therapy of hypophosphatasia
|
|
MA43348A
(fr)
|
2015-10-01 |
2018-08-08 |
Novo Nordisk As |
Conjugués de protéines
|
|
WO2017059168A1
(en)
*
|
2015-10-01 |
2017-04-06 |
Heat Biologics, Inc. |
Compositions and methods for adjoining type i and type ii extracellular domains as heterologous chimeric proteins
|
|
US10040840B2
(en)
|
2015-10-02 |
2018-08-07 |
Silver Creek Pharmaceuticals, Inc. |
Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue
|
|
US20170095577A1
(en)
*
|
2015-10-06 |
2017-04-06 |
Washington University |
Noninvasive imaging of focal atherosclerotic lesions using fluorescence molecular tomography
|
|
EP3368062A4
(en)
|
2015-10-30 |
2019-07-03 |
Alexion Pharmaceuticals, Inc. |
METHODS OF TREATING CRANIOSYNOSTOSIS IN A PATIENT
|
|
EP3395366B1
(en)
*
|
2015-12-21 |
2023-11-22 |
Hefei Lifeon Pharmaceutical Co., Ltd. |
Drug design method, obtained drug and application thereof
|
|
AU2016381964B2
(en)
|
2015-12-30 |
2024-02-15 |
Kodiak Sciences Inc. |
Antibodies and conjugates thereof
|
|
KR20170079409A
(ko)
*
|
2015-12-30 |
2017-07-10 |
한미약품 주식회사 |
지속형 인간 성장 호르몬 결합체의 신규 액상 제제
|
|
MX2018008128A
(es)
|
2015-12-31 |
2018-12-06 |
Hanmi Pharm Ind Co Ltd |
Conjugado persistente de triple activador que activa el receptor de glucagon, glp-1 y gip.
|
|
CA3011455A1
(en)
|
2016-01-27 |
2017-08-03 |
Sutro Biopharma, Inc. |
Anti-cd74 antibody conjugates, compositions comprising anti-cd74 antibody conjugates and methods of using anti-cd74 antibody conjugates
|
|
AR107483A1
(es)
*
|
2016-01-29 |
2018-05-02 |
Hanmi Pharm Ind Co Ltd |
Conjugado de enzimas terapéuticas
|
|
US11065306B2
(en)
|
2016-03-08 |
2021-07-20 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in children
|
|
WO2017173413A1
(en)
|
2016-04-01 |
2017-10-05 |
Alexion Pharmaceuticals, Inc. |
Treating muscle weakness with alkaline phosphatases
|
|
EP3436020A4
(en)
|
2016-04-01 |
2019-12-25 |
Alexion Pharmaceuticals, Inc. |
METHOD FOR TREATING HYPOPHOSPHATASIE IN TEENS AND ADULTS
|
|
US11208632B2
(en)
|
2016-04-26 |
2021-12-28 |
R.P. Scherer Technologies, Llc |
Antibody conjugates and methods of making and using the same
|
|
EP3453758A4
(en)
|
2016-05-02 |
2019-12-04 |
Ajinomoto Co., Inc. |
FC PROTEIN WITH AZID GROUP
|
|
CN106008722B
(zh)
*
|
2016-05-13 |
2019-10-15 |
未名生物医药有限公司 |
一种重组β-hNGF-Fc融合蛋白、制备方法及用途
|
|
WO2017214130A1
(en)
|
2016-06-06 |
2017-12-14 |
Alexion Pharmaceuticals, Inc. |
Metal impact on manufacturing of alkaline phosphatases
|
|
US11034775B2
(en)
|
2016-06-07 |
2021-06-15 |
Gliknik Inc. |
Cysteine-optimized stradomers
|
|
MX2019000019A
(es)
|
2016-06-29 |
2019-05-06 |
Hanmi Pharm Ind Co Ltd |
Derivado de glucagon, conjugado del mismo, composicion que comprende el mismo y uso terapeutico del mismo.
|
|
US11116821B2
(en)
|
2016-08-18 |
2021-09-14 |
Alexion Pharmaceuticals, Inc. |
Methods for treating tracheobronchomalacia
|
|
JOP20190019A1
(ar)
*
|
2016-08-30 |
2019-02-12 |
Genexine Inc |
تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH)
|
|
KR102698929B1
(ko)
|
2016-09-23 |
2024-08-27 |
한미약품 주식회사 |
인슐린 수용체와의 결합력이 감소된, 인슐린 아날로그 및 이의 용도
|
|
JOP20190085A1
(ar)
|
2016-10-20 |
2019-04-17 |
Biogen Ma Inc |
طرق علاج الضمور العضلي ومرض العظام باستخدام بروتينات احتجاز مركب ترابطي actriib هجين حديثة
|
|
WO2018105988A1
(ko)
*
|
2016-12-05 |
2018-06-14 |
한미약품 주식회사 |
면역반응이 약화된 결합체
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
CA3043251A1
(en)
|
2016-12-09 |
2018-06-14 |
Gliknik Inc. |
Methods of treating inflammatory disorders with multivalent fc compounds
|
|
CA3043261A1
(en)
|
2016-12-09 |
2018-06-14 |
Gliknik Inc. |
Manufacturing optimization of gl-2045, a multimerizing stradomer
|
|
AU2018215840A1
(en)
*
|
2017-02-03 |
2019-08-01 |
Hanmi Pharm. Co., Ltd. |
Long-Acting Conjugate Of A Physiologically Active Material And Use Thereof
|
|
CA3054132A1
(en)
|
2017-02-27 |
2018-08-30 |
Shattuck Labs, Inc. |
Csf1r-based chimeric proteins
|
|
WO2018157165A1
(en)
|
2017-02-27 |
2018-08-30 |
Shattuck Labs, Inc. |
Methods of making and using extracellular domain-based chimeric proteins
|
|
JP7604098B2
(ja)
|
2017-03-23 |
2024-12-23 |
ハンミ ファーマシューティカル カンパニー リミテッド |
インスリン受容体との結合力が減少されたインスリンアナログの結合体及びその用途
|
|
EP3600383A4
(en)
|
2017-03-31 |
2020-10-28 |
Alexion Pharmaceuticals, Inc. |
METHODS OF TREATMENT OF HYPOPHOSPHATASIA (HPP) IN ADULTS AND ADOLESCENTS
|
|
MA49339A
(fr)
*
|
2017-04-05 |
2020-02-12 |
Novo Nordisk As |
Conjugués insuline-fc à extension oligomère
|
|
US20200131225A1
(en)
*
|
2017-04-20 |
2020-04-30 |
Novo Nordisk A/S |
Methods of purification of albumin fusion proteins
|
|
WO2018195338A1
(en)
|
2017-04-20 |
2018-10-25 |
Atyr Pharma, Inc. |
Compositions and methods for treating lung inflammation
|
|
CN109206522B
(zh)
*
|
2017-07-07 |
2021-11-09 |
北京三有利和泽生物科技有限公司 |
一种长效抗凝血融合蛋白及其应用
|
|
JP6566324B2
(ja)
*
|
2017-09-29 |
2019-08-28 |
サイデン化学株式会社 |
粘着シート
|
|
WO2019066603A1
(ko)
|
2017-09-29 |
2019-04-04 |
한미약품 주식회사 |
효력이 향상된 지속성 단백질 결합체
|
|
EP3692070A1
(en)
|
2017-10-02 |
2020-08-12 |
Denali Therapeutics Inc. |
Fusion proteins comprising enzyme replacement therapy enzymes
|
|
KR20190045081A
(ko)
*
|
2017-10-23 |
2019-05-02 |
주식회사 프로젠 |
변형된 egf 단백질 및 이를 유효성분으로 포함하는 피부 상태 개선용 화장료 조성물
|
|
KR102167827B1
(ko)
*
|
2017-12-20 |
2020-10-20 |
주식회사 알테오젠 |
신규한 성장 호르몬 수용체 길항제 및 이의 융합 단백질
|
|
CN108218998A
(zh)
*
|
2017-12-31 |
2018-06-29 |
武汉班科生物技术股份有限公司 |
一种突变型人源IgG的Fc片段及其制备方法与应用
|
|
KR101974305B1
(ko)
*
|
2018-02-14 |
2019-04-30 |
한미사이언스 주식회사 |
생리활성 폴리펩타이드 결합체 제조 방법
|
|
WO2019169341A1
(en)
|
2018-03-02 |
2019-09-06 |
Kodiak Sciences Inc. |
Il-6 antibodies and fusion constructs and conjugates thereof
|
|
AU2019242586B2
(en)
*
|
2018-03-26 |
2025-09-11 |
Regeneron Pharmaceuticals, Inc. |
Humanized rodents for testing therapeutic agents
|
|
KR102209108B1
(ko)
|
2018-03-27 |
2021-01-28 |
국립암센터 |
Oct4 기능 저해용 펩티드를 포함하는 줄기세포성 억제용 조성물
|
|
JP2021519590A
(ja)
|
2018-03-30 |
2021-08-12 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
糖タンパク質の製造
|
|
WO2019199685A1
(en)
|
2018-04-09 |
2019-10-17 |
Amgen Inc. |
Growth differentiation factor 15 fusion proteins
|
|
WO2020033867A2
(en)
|
2018-08-10 |
2020-02-13 |
Alexion Pharmaceuticals, Inc. |
Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase
|
|
US10780121B2
(en)
|
2018-08-29 |
2020-09-22 |
Shattuck Labs, Inc. |
FLT3L-based chimeric proteins
|
|
PE20220500A1
(es)
*
|
2019-04-23 |
2022-04-07 |
Lg Chemical Ltd |
POLIPEPTIDO DE FUSION QUE COMPRENDE LA REGION Fc DE INMUNOGLOBULINA Y GDF15
|
|
US11267858B2
(en)
*
|
2019-05-31 |
2022-03-08 |
Spectrum Pharmaceuticals, Inc. |
Methods of treatment using G-CSF protein complex
|
|
CN112142850A
(zh)
*
|
2019-06-27 |
2020-12-29 |
深圳市卫光生物制品股份有限公司 |
人神经生长因子-乳铁蛋白重组蛋白及用途
|
|
CN114786731A
(zh)
|
2019-10-10 |
2022-07-22 |
科达制药股份有限公司 |
治疗眼部病症的方法
|
|
CN110669134A
(zh)
*
|
2019-10-15 |
2020-01-10 |
广东菲鹏生物有限公司 |
IgM-FC片段、IgM-FC抗体及制备方法和应用
|
|
AU2020398898A1
(en)
|
2019-12-09 |
2022-07-21 |
Alexion Pharmaceuticals, Inc. |
Alkaline phosphatase polypeptides and methods of use thereof
|
|
CN114867739B
(zh)
*
|
2019-12-11 |
2025-04-08 |
株式会社Lg化学 |
包含gdf15和能够进行o-糖基化的多肽区的融合多肽
|
|
CN111153996B
(zh)
*
|
2020-01-10 |
2021-12-14 |
苏州睿瀛生物技术有限公司 |
G蛋白偶联受体的抗体及其制备方法和g蛋白偶联受体试剂盒
|
|
CN111505291B
(zh)
*
|
2020-04-14 |
2023-04-25 |
山东省千佛山医院 |
一种排除巨酶分子对血清酶浓度检测带来干扰的方法
|
|
KR20210144608A
(ko)
|
2020-05-22 |
2021-11-30 |
한미약품 주식회사 |
액상 제제
|
|
CN112098639B
(zh)
*
|
2020-09-21 |
2024-01-02 |
天津医科大学 |
以氧化石墨烯为载体的二抗的合成及应用
|
|
MX2023005235A
(es)
*
|
2020-11-03 |
2023-10-16 |
Protalix Ltd |
Uricasa modificada y usos de la misma.
|
|
US12083169B2
(en)
|
2021-02-12 |
2024-09-10 |
Alexion Pharmaceuticals, Inc. |
Alkaline phosphatase polypeptides and methods of use thereof
|
|
AU2022339767A1
(en)
|
2021-08-30 |
2024-04-11 |
Lassen Therapeutics, Inc. |
Anti-il-11rα antibodies
|
|
AU2023213963A1
(en)
*
|
2022-01-28 |
2024-07-18 |
argenx BV |
Anti-musk antibodies for use in treating neuromuscular disorders
|
|
AU2023228691A1
(en)
*
|
2022-03-03 |
2024-09-19 |
The Trustees Of The University Of Pennsylvania |
Viral vectors encoding parathyroid hormone fusions and uses thereof in treating hypoparathyroidism
|
|
CN114588315A
(zh)
*
|
2022-03-14 |
2022-06-07 |
东莞市人民医院 |
抗炎蛋白涂层的制备方法、生物工程功能材料及其应用
|
|
WO2024123675A2
(en)
*
|
2022-12-05 |
2024-06-13 |
Alexion Pharmaceuticals, Inc. |
Taci-fc fusion proteins for multifunctional inhibition of baff, april, and neonatal fc receptor
|
|
WO2024148241A1
(en)
|
2023-01-06 |
2024-07-11 |
Lassen Therapeutics 1, Inc. |
Anti-il-18bp antibodies
|
|
KR20250133728A
(ko)
|
2023-01-06 |
2025-09-08 |
라센 테라퓨틱스, 인코포레이티드 |
항-il-18bp 항체
|
|
TW202434642A
(zh)
|
2023-01-06 |
2024-09-01 |
美商拉森醫療公司 |
用於治療甲狀腺眼病之抗ＩＬ—１１Ｒα抗體
|